ghk-cu injection site reactions reaction Redness & Welting 💙, A small red bump or welt after ghk cu injection skin before

Progress load by no more than 10% per week once pain is consistently below 3/10 on the Numeric Rating Scale

68-week bone density data showed no significant changes from baseline

Molecular Weight: 286.11 g/mol (as iodide salt)

Composition BPC-157: 5 mg Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Peptide identity and purity assessment Assay development and calibration for quantitative analysis Chromatographic method optimization for impurity profiling Stability characterization of a lyophilized peptide under laboratory storage conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability

Food and Drug Administration Updated 503A bulk drug substances list (Category 2 revision, effective April 22, 2026)

BPC-157 interacts with the bodys growth factors to promote angiogenesisthe formation of new blood vesselsand accelerate healing in muscles, joints, tendons, and even the gastrointestinal tract